Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.42 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.42 |
| ▸ | ITGAL | P20701 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 6/20 | 0.40 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | GNPAT | O15228 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5613494 | 1.00 | ECE1 (0.53) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL546997 | 1.00 | ECE1 (0.53) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL7022643 | 1.00 | ECE1 (0.53) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL30052291 | 0.93 | ECE1 (0.50) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL7184807 | 0.93 | ECE1 (0.50) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL16401 | 0.93 | ECE1 (0.50) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL31707359 | 0.92 | TGFBR1 (0.47) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL29591087 | 0.91 | ECE1 (0.46) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL8087169 | 0.91 | ECE1 (0.46) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL700301 | 0.91 | ECE1 (0.46) | ECE1MEN1KMT2AITGB2ICAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 784 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3162893-B1 | MUTANT-TYPE GLUCOSE DEHYDROGENASE AND USE THEREOF | ARKRAY INC (JP) | 2020-02-19 | — | — | EP | claimed |
| CN-107058249-A | Mutant glucose dehydrogenase and its use | 爱科来株式会社 | 2017-08-18 | — | — | CN | claimed |
| EP-3162893-A1 | MUTANT-TYPE GLUCOSE DEHYDROGENASE AND USE THEREOF | ARKRAY, Inc. (JP) | 2017-05-03 | — | — | EP | claimed |
| CN-105753983-A | Binding Proteins Specific For Insulin-like Growth Factors And Uses Thereof | 阿斯利康(瑞典)有限公司 | 2016-07-13 | — | — | CN | claimed |
| CN-102161703-A | Method for preparing monoclonal antibody resisting human neuropilin-1 | UNIV XIAMEN | 2011-08-24 | — | — | CN | claimed |
| WO-2001070980-A9 | ISOLATED G-PROTEIN COUPLED RECEPTORS, NUCLEIC ACID MOLECULES ENCODING GPCR PROTEINS, AND USES THEREOF AS INSECTICIDAL TARGETS | PE CORP NY (US) | 2003-01-16 | — | — | WO | claimed |
| CN-113354732-B | Human antibodies against ebola virus glycoprotein | 瑞泽恩制药公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-112955463-B | Anti-CXCR 2 antibodies and uses thereof | 赛福伦有限责任公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-113710660-B | DOT1L degradation agent and application thereof | 达纳-法伯癌症研究公司 | 2024-07-02 | — | — | CN | disclosed |
| EP-4387994-A1 | IGA MONOCLONAL ANTIBODIES FOR TREATING FLAVIVIRUS INFECTION | The Research Foundation for the State University of New York (US) | 2024-06-26 | — | — | EP | disclosed |
| CN-115141272-B | Novel coronavirus monoclonal antibody XY1 and application thereof | 中南大学湘雅医院 | 2024-06-25 | — | — | CN | disclosed |
| CN-115109150-B | Novel coronavirus monoclonal antibody XY10 and application thereof | 中南大学湘雅医院 | 2024-06-25 | — | — | CN | disclosed |
| CN-115109151-B | Novel coronavirus monoclonal antibody XY6 and application thereof | 中南大学湘雅医院 | 2024-06-11 | — | — | CN | disclosed |
| WO-1995007706-A1 | THE SEMAPHORIN GENE FAMILY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-03-23 | — | — | WO | disclosed |
| WO-1995007353-A2 | BINDING DOMAINS FROM PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM ERYTHROCYTE BINDING PROTEINS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-03-16 | — | — | WO | disclosed |
| WO-1994025583-A1 | A RECOMBINANT TRYPSIN-LIKE PROTEASE | NOVO NORDISK A/S (DK) | 1994-11-10 | — | — | WO | disclosed |
| WO-1994016076-A1 | ANTIMICROBIAL-PROTEIN-PRODUCING ENDOSYMBIOTIC MICROORGANISMS | ZENECA LIMITED (GB) | 1994-07-21 | — | — | WO | disclosed |
| WO-1994000579-A1 | MODIFIED KLUYVEROMYCES YEASTS, THEIR PREPARATION AND USE | RHONE-POULENC RORER S.A. (FR) | 1994-01-06 | — | — | WO | disclosed |
| WO-1993025685-A1 | CLONING AND CHARACTERIZATION OF THE CELL DEATH GENES CED-3 AND CED-4 | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1993-12-23 | — | — | WO | disclosed |
| WO-1993020237-A1 | HOMOLOGY CLONING | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1993-10-14 | — | — | WO | disclosed |